REFERENCES
1. Wosik J, Fudim M, Cameron B, Gellad ZF, Cho A, Phinney D, et al.
Telehealth transformation: COVID-19 and the rise of virtual care.
Journal of the American Medical Informatics Association.
2020;27(6):957-62.
2. Goldman HB, Haber GP. Recommendations for Tiered Stratification of
Urological Surgery Urgency in the COVID-19 Era. Journal of Urology.
2020;204(1):11-3.
3. Stensland KD, Morgan TM, Moinzadeh A, Lee CT, Briganti A, Catto JWF,
et al. Considerations in the Triage of Urologic Surgeries During the
COVID-19 Pandemic. European urology. 2020;77(6):663-6.
4. Wallis CJD, Novara G, Marandino L, Bex A, Kamat AM, Karnes RJ, et al.
Risks from Deferring Treatment for Genitourinary Cancers: A
Collaborative Review to Aid Triage and Management During the COVID-19
Pandemic. European urology. 2020;78(1):29-42.
5. Russell B, Liedberg F, Khan MS, Nair R, Thurairaja R, Malde S, et al.
A Systematic Review and Meta-analysis of Delay in Radical Cystectomy and
the Effect on Survival in Bladder Cancer Patients. European urology
oncology. 2020;3(2):239-49.
6. van den Bergh RC, Albertsen PC, Bangma CH, Freedland SJ, Graefen M,
Vickers A, et al. Timing of curative treatment for prostate cancer: a
systematic review. European urology. 2013;64(2):204-15.
7. Berenguer J, Ryan P, Rodríguez-Baño J, Jarrín I, Carratalà J, Pachón
J, et al. Characteristics and predictors of death among 4,035
consecutively hospitalized patients with COVID-19 in Spain. Clinical
Microbiology and Infection. 2020.
8. Liang W, Guan W, Chen R, Wang W, Li J, Xu K, et al. Cancer patients
in SARS-CoV-2 infection: a nationwide analysis in China. The Lancet
Oncology. 2020;21(3):335-7.
9. Miyashita H, Mikami T, Chopra N, Yamada T, Chernyavsky S, Rizk D, et
al. Do patients with cancer have a poorer prognosis of COVID-19? An
experience in New York City. Annals of oncology : official journal of
the European Society for Medical Oncology. 2020;31(8):1088-9.
10. Kuderer NM, Choueiri TK, Shah DP, Shyr Y, Rubinstein SM, Rivera DR,
et al. Clinical impact of COVID-19 on patients with cancer (CCC19): a
cohort study. Lancet (London, England). 2020;395(10241):1907-18.
11. Lee A, Naksukpaiboon P. COVID-19 mortality in patients with cancer
on chemotherapy or other anticancer treatments: a prospective cohort
study. The Lancet. 2020;395.
12. Robilotti EV, Babady NE, Mead PA, Rolling T, Perez-Johnston R,
Bernardes M, et al. Determinants of COVID-19 disease severity in
patients with cancer. Nature Medicine. 2020;26(8):1218-23.
13. Chen Y-T, Shao S-C, Hsu C-K, Wu IW, Hung M-J, Chen Y-C. Incidence of
acute kidney injury in COVID-19 infection: a systematic review and
meta-analysis. Critical Care. 2020;24(1):346.
14. Yang X, Jin Y, Li R, Zhang Z, Sun R, Chen D. Prevalence and impact
of acute renal impairment on COVID-19: a systematic review and
meta-analysis. Critical Care. 2020;24(1):356.
15. Belayev LY, Palevsky PM. The link between acute kidney injury and
chronic kidney disease. Current opinion in nephrology and hypertension.
2014;23(2):149-54.
16. Santos MLC, de Brito BB, da Silva FAF, Botelho A, de Melo FF.
Nephrotoxicity in cancer treatment: An overview. World journal of
clinical oncology. 2020;11(4):190-204.
17. Kumar RK, Sammon JD, Kaczmarek BF, Khalifeh A, Gorin MA, Sivarajan
G, et al. Robot-assisted partial nephrectomy in patients with baseline
chronic kidney disease: a multi-institutional propensity score-matched
analysis. European urology. 2014;65(6):1205-10.
18. Ning C, Hu X, Liu F, Lin J, Zhang J, Wang Z, et al. Post-surgical
outcomes of patients with chronic kidney disease and end stage renal
disease undergoing radical prostatectomy: 10-year results from the US
National Inpatient Sample. BMC nephrology. 2019;20(1):278.
19. Hamano I, Hatakeyama S, Iwamurau H, Fujita N, Fukushi K, Narita T,
et al. Preoperative chronic kidney disease predicts poor oncological
outcomes after radical cystectomy in patients with muscle-invasive
bladder cancer. Oncotarget. 2017;8(37):61404-14.
20. Berlin DA, Gulick RM, Martinez FJ. Severe Covid-19. The New England
journal of medicine. 2020.
21. Giannakoulis VG, Papoutsi E, Siempos II. Effect of Cancer on
Clinical Outcomes of Patients With COVID-19: A Meta-Analysis of Patient
Data. JCO Global Oncology. 2020(6):799-808.
22. NYC Department of Health COVID19 Data Page [Available from:
https://www1.nyc.gov/site/doh/covid/covid-19-data-archive.page.
23. Sprung CL, Joynt GM, Christian MD, Truog RD, Rello J, Nates JL.
Adult ICU Triage During the Coronavirus Disease 2019 Pandemic: Who Will
Live and Who Will Die? Recommendations to Improve Survival. Critical
care medicine. 2020;48(8):1196-202.
24. Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS.
Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor:
molecular mechanisms and potential therapeutic target. Intensive Care
Medicine. 2020;46(4):586-90.
25. Larrinaga G, Pérez I, Sanz B, Blanco L, López JI, Cándenas ML, et
al. Angiotensin-converting enzymes (ACE and ACE2) are downregulated in
renal tumors. Regulatory peptides. 2010;165(2-3):218-23.